David A Yurek
- Molecular Medicine top 10%
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 7
-
- Antifungal resistance and susceptibility 2
-
- Analytical Chemistry and Chromatography 3
-
- Bioactive Compounds and Antitumor Agents 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Synthesis and Biological Activity 2
-
- Cancer therapeutics and mechanisms 2
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- M. S. KUOMing‐Shang KuoBülent BozdoğanRoland LeclercqJ. H. COATSBrian J. StockmanKathleen A. FarleyS. A. MIZSAK
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
David A Yurek
23 papers receiving 429 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 44
- Pharmacology 99
- Biotechnology 34
- Biochemistry 28
- Infectious Diseases 71
Countries citing papers authored by David A Yurek
This map shows the geographic impact of David A Yurek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A Yurek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A Yurek more than expected).
Fields of papers citing papers by David A Yurek
This network shows the impact of papers produced by David A Yurek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A Yurek. The network helps show where David A Yurek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David A Yurek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 15 | |
| 2 | 2016 | 25 | |
| 3 | 2014 | 3 | |
| 4 | 2013 | 8 | |
| 5 | HPLC-MS/MS for Hit Generation | 2013 | 1 |
| 6 | 2002 | 55 | |
| 7 | 2001 | 3 | |
| 8 | 1999 | 6 | |
| 9 | 1999 | 13 | |
| 10 | 1996 | 9 | |
| 11 | 1995 | 8 | |
| 12 | 1992 | 23 | |
| 13 | 1991 | 12 | |
| 14 | 1991 | 4 | |
| 15 | 1990 | 1 | |
| 16 | 1990 | 6 | |
| 17 | 1989 | 27 | |
| 18 | 1989 | 21 | |
| 19 | 1989 | 20 | |
| 20 | 1989 | 30 |
About David A Yurek
David A Yurek is a scholar working on Toxicology, Pharmacology and Cancer Research, having authored 23 papers that have together received 448 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (7 papers), Analytical Chemistry and Chromatography (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Antifungal resistance and susceptibility (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Synthesis and Biological Activity (2 papers), Cancer therapeutics and mechanisms (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Molecular Medicine (44 citations), Pharmacology (99 citations) and Biotechnology (34 citations). David A Yurek has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include M. S. KUO, Ming‐Shang Kuo, Bülent Bozdoğan, Roland Leclercq, J. H. COATS, Brian J. Stockman, Kathleen A. Farley, S. A. MIZSAK, J. I. CIALDELLA and V. P. MARSHALL.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.